About us
MANAGEMENT TEAM
Investment strategy
Portfolio
News
Contact
Private Area
Portfolio
Home
Portfolio
An efficient frontier: a diversified portfolio with an optimised risk-return ratio
ALETA BIOTHERAPEUTICS
FUND 3 / INVESTED
Algenex
EXIT / FUND 2
ARTAX BIOPHARMA
FUND 2 / INVESTED
ASKBIO
EXIT / FUND 1 / FUND 2
AURA BIOSCIENCES
EXIT / FUND 1 / FUND 3
COCOON
FUND 2 / INVESTED
CURAPATH
EXIT / FUND 1
Highlight Therapeutics
FUND 2 / INVESTED
INTEGRA THERAPEUTICS
FUND 3 / INVESTED
JURATA THIN FILM
FUND 3 / INVESTED
MINORYX THERAPEUTICS
FUND 3 / INVESTED
NERRE THERAPEUTICS
FUND 3 / INVESTED
RADIOTERAPIA DE PROTONES
FUND 1 / INVESTED
Recovid Solutions
EXIT / FUND 2
SANIFIT THERAPEUTICS
EXIT / FUND 2
SYNGOI TECHNOLOGIES
FUND 3 / INVESTED
TAAV
EXIT / FUND 1 / FUND 2
Tyris Therapeutics
FUND 2 / INVESTED
Viralgen Commercial
EXIT / FUND 2
Viralgen Vector Core
EXIT / FUND 1
VIVET THERAPEUTICS
FUND 1 / INVESTED